Our story
The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence. Through innovation and meeting medical needs, we will expand our proprietary technology to improve patients’ quality of life and treatment outcomes. Our winning aspiration is driven by generating clinically reliable data to build value in our technology and move quickly to market.
Our Group includes two operative companies with excellent success records operating under the Magle Group banner. Magle Chemoswed AB is a contract development and manufacturing organization (CDMO) that has rapidly built a strong reputation for its expertise, innovation, and high-quality development and manufacturing expertise. PharmaCept GmbH is dedicated to bringing DSM products to the market through our sales and marketing force.
